Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gastrectomy with HIPEC vs without HIPEC for prevention of peritoneal carcinomatosis in gastric cancer
2011-004405-25Phase 4Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of mitomycin c and cisplatin in gastric adenocarcinoma and peritoneal carcinomatosis (PC) (2 arms), sponsored by University Hospital Tübingen. Primary endpoint: progression of peritoneal carcinomatosis. Started Jan 2012; status: terminated.
02
Drugs
mitomycin ccisplatin
03
Conditions
gastric adenocarcinomaperitoneal carcinomatosis (PC)
Beyond the preview
Go deeper on 2011-004405-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004405-25.